Journal article
[Progressive multifocal leukoencephalopathy].
-
Warnke C
Klinik für Neurologie, Medizinische Fakultät, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Deutschland. warnke@uni-duesseldorf.de.
-
Wattjes MP
Abteilung für Radiologie und Nuklearmedizin, VU University Medical Center, Amsterdam, Niederlande.
-
Adams O
Institut für Virologie, Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Deutschland.
-
Hartung HP
Klinik für Neurologie, Medizinische Fakultät, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Deutschland.
-
Martin R
Klinik für Neurologie, Universitätsspital Zürich, Zürich, Schweiz.
-
Weber T
Klinik für Neurologie, Kath. Marienkrankenhaus, Hamburg, Deutschland.
-
Stangel M
Klinik für Neurologie, Medizinische Hochschule Hannover, Hannover, Deutschland.
Show more…
English
Progressive multifocal leukoencephalopathy (PML) is a disease of immunosuppressed patients caused by the JC polyomavirus (JCPyV). Due to the elevated risk in patients treated with natalizumab for multiple sclerosis (MS) and also treatment with other biologicals for different indications, the relevance of PML has increased in recent years. This article summarizes the published knowledge on the biology and pathogenesis of PML with a focus on the role of cerebrospinal fluid diagnostics in the work-up for PML and the current PML case definition. Current recommendations regarding risk management are discussed, as are possible therapies and prevention.
-
Language
-
-
Open access status
-
closed
-
Identifiers
-
-
Persistent URL
-
https://folia.unifr.ch/global/documents/260381
Statistics
Document views: 18
File downloads: